Dean Heller sold Morgan Stanley (NYSE: MS)
Dean Heller (R-NV), a U.S. Senator, has disclosed 1 trade in Morgan Stanley (MS) since 2018, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Dean Heller sold $1,001 - $15,000 of Morgan Stanley (NYSE: MS) on December 6, 2018. Since that trade, MS is up +499.21% against the S&P 500 up +203.18%, an outperformance of +296.03%.
Data updated
Dean Heller's MS trades vs the price
MS is up +499.21% since Dean Heller sold on December 6, 2018, versus +203.18% for the S&P 500.
Performance since this trade
All Dean Heller MS trades
Dean Heller & MS trading FAQ
Is it legal for Dean Heller to trade Morgan Stanley (MS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Morgan Stanley (MS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Dean Heller sell MS?
Dean Heller disclosed a sale of $1,001 - $15,000 of Morgan Stanley (MS) on December 6, 2018, according to public STOCK Act filings.
How has MS performed since Dean Heller's trade?
Since Dean Heller sold MS on December 6, 2018, the stock is up +499.21%, versus +203.18% for the S&P 500 over the same period, an outperformance of +296.03%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional MS trades?
Quantellect tracks every disclosed congressional trade in Morgan Stanley (MS) on the Morgan Stanley congressional trading page, which aggregates filings across all members of Congress.
Dean Heller's MS tradesAll congressional filings for Morgan StanleyDean Heller's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.